Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy (NYSE:ABT)
· seekingalpha.com
Abbott is rated Hold due to increased leverage and the need for Exact Sciences to deliver a meaningful FCF contribution. Click for more on the ABT stock.
The main question of the investment thesis for Abbott Laboratories ( ABT ) is not connected with the quality of the business as such. The company still has stro...